Faculty. Ben Ho Park, MD, Ph. DProfessor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The overall goal of Dr. Park's research is to develop. DNA for individualized therapies in early stage breast. Park trained as a. Bert Vogelstein at Johns Hopkins, where he gained. Since starting his own independent research. The work discussed here is currently a prime focus of his. Park is a well- established investigator. DNA as biomarkers for detecting residual disease and. The Brain Tumor Center (BTRC) at UCSF is internationally recognized as a major research and treatment center for adults and children with tumors of the brain and spinal cord. The basic science laboratories of the BTRC and the.These studies include: 1. Higgins MJ, Jelovac D, Barnathan E, Blair B, Slater S. Powers P, Zorzi J, Jeter SC, Oliver GR, Fetting J, Emens L, Riley C, Stearns V. Diehl F, Angenendt P, Huang P, Cope L, Argani P, Murphy KM, Bachman KE. Greshock J, Wolff AC, Park BH. Detection of tumor PIK3. CA status in metastatic. Jun. 1. 5; 1. 8(1. Pub. Med PMID: 2. Pub. Med Central PMCID: PMC3. Beaver JA, Jelovac D, Balukrishna S, Cochran RL. Croessmann S, Zabransky DJ, Wong HY, Valda Toro P, Cidado J, Blair BG, Chu D. Burns T, Higgins MJ, Stearns V, Jacobs L, Habibi M, Lange J, Hurley PJ, Lauring. J, Van. Den. Berg DA, Kessler J, Jeter S, Samuels ML, Maar D, Cope L. Cimino- Mathews A, Argani P, Wolff AC, Park BH. Detection of cancer DNA in. May. 1. 5; 2. 0(1. Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015, 2016, and 2017 (P50). The Translational Research Program (TRP) is the home of the SPOREs — the Specialized Programs of Research Excellence — a cornerstone of NCI’s efforts to promote collaborative, interdisciplinary translational cancer. This section contains resources to assist FIU researchers identify funding opportunities. As you navigate through this page, you will find a listing of internal and external opportunities as well as a host of tools that can. Niroshana Anandasabapathy, M.D., Ph.D. Rachael Clark, M.D., Ph.D Charles Dimitroff, Ph.D. Robert Fuhlbrigge, M.D., Ph.D. Pub. Med PMID: 2. Pub. Med Central PMCID: PMC4. Toro PV, Erlanger B, Beaver JA, Cochran RL, Van. Den. Berg. DA, Yakim E, Cravero K, Chu D, Zabransky DJ, Wong HY, Croessmann S, Parsons H. Hurley PJ, Lauring J, Park BH. Comparison of cell stabilizing blood collection. DNA. 2. 01. 5 Jul 3. Pub. Med PMID. 2. Chu D, Paoletti C, Gersch C, Van. Den. Berg D, Zabransky. D, Cochran R, Wong HY, Valda Toro P, Cidado J, Croessmann S, Erlanger B. Cravero K, Kyker- Snowman K, Button B, Parsons H, Dalton WB, Gillani R, Medford. A, Aung K, Tokudome N, Chinnaiyan A, Schott AF, Robinson DR, Jacks K, Lauring. J, Hurley PJ, Hayes DF, Rae JM, Park BH. ESR1 mutations in circulating plasma. DNA from metastatic breast cancer patients. Aug. 1. 0; Pub. Med PMID: 2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |